These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6116624)

  • 1. Identification of the part of kirromycin structure that acts on elongation factor Tu.
    Chinali G
    FEBS Lett; 1981 Aug; 131(1):94-8. PubMed ID: 6116624
    [No Abstract]   [Full Text] [Related]  

  • 2. A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycin.
    Duisterwinkel FJ; De Graaf JM; Schretlen PJ; Kraal B; Bosch L
    Eur J Biochem; 1981 Jun; 117(1):7-12. PubMed ID: 7021158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GTPase activity of elongation factor Tu and the 3'-terminal end of aminoacyl-tRNA.
    Parlato G; Guesnet J; Crechet JB; Parmeggiani A
    FEBS Lett; 1981 Mar; 125(2):257-60. PubMed ID: 6112171
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetic aspects of the EF-Tu-dependent GTPase activity. A study using the antibiotic kirromycin.
    Bocchini V; Parlato G; De Vendittis E; Sander G; Parmeggiani A
    Eur J Biochem; 1980 Dec; 113(1):53-60. PubMed ID: 6109630
    [No Abstract]   [Full Text] [Related]  

  • 6. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
    Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
    EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.
    Chinali G
    J Antibiot (Tokyo); 1981 Aug; 34(8):1039-45. PubMed ID: 6119303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
    Pingoud A; Block W; Urbanke C; Wolf H
    Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The excess GTP hydrolyzed during mistranslation is expended at the stage of EF-Tu-promoted binding of non-cognate aminoacyl-tRNA.
    Kakhniashvili DG; Smailov SK; Gavrilova LP
    FEBS Lett; 1986 Feb; 196(1):103-7. PubMed ID: 3510907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single turnover kinetic studies of guanosine triphosphate hydrolysis and peptide formation in the elongation factor Tu-dependent binding of aminoacyl-tRNA to Escherichia coli ribosomes.
    Thompson RC; Dix DB; Eccleston JF
    J Biol Chem; 1980 Dec; 255(23):11088-90. PubMed ID: 7002916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
    Ivell R; Fasano O; Crechet JB; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1355-61. PubMed ID: 7013793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
    Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
    J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative study of the interaction of aminoacyl-tRNA with the a site of Escherichia coli ribosomes: equilibrium and kinetic parameters of binding in the absence of EF-Tu factor and GTP.
    Kemkhadze KS; Odintsov VB; Semenkov YP; Kirillov SV
    FEBS Lett; 1981 Mar; 125(1):10-4. PubMed ID: 7014250
    [No Abstract]   [Full Text] [Related]  

  • 15. The rate of cleavage of GTP on the binding of Phe-tRNA.elongation factor Tu.GTP to poly(U)-programmed ribosomes of Escherichia coli.
    Eccleston JF; Dix DB; Thompson RC
    J Biol Chem; 1985 Dec; 260(30):16237-41. PubMed ID: 3905812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulvomycin-resistant mutants of E.coli elongation factor Tu.
    Zeef LA; Bosch L; Anborgh PH; Cetin R; Parmeggiani A; Hilgenfeld R
    EMBO J; 1994 Nov; 13(21):5113-20. PubMed ID: 7957075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
    Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
    Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
    Jacquet E; Parmeggiani A
    Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a model for the interaction between elongation factor Tu and the ribosome.
    Weijland A; Parmeggiani A
    Science; 1993 Feb; 259(5099):1311-4. PubMed ID: 8446899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of glutamine 290 in Escherichia coli and mitochondrial elongation factor Tu affects interactions with mitochondrial aminoacyl-tRNAs and GTPase activity.
    Hunter SE; Spremulli LL
    Biochemistry; 2004 Jun; 43(22):6917-27. PubMed ID: 15170329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.